OPA1 and ischemic stroke: Collectively, these three studies underscore the potential clinical benefits of NTG in ischemic stroke, mediated through blood pressure reduction, enhanced collateral circulation, and direct neuroprotective effects across diverse patient populations and therapeutic time windows.